Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive
Clinical trial NCT02279862 · COMPLETED
Trial details
- NCT number
- NCT02279862
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-02
- Primary completion
- 2016-12-15
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.